About this source
- Kind
- Research
- Design
- Human clinical trial, RCT
- Population
- About 5,500 adults with obesity and established cardiovascular disease, chronic kidney disease or cardiovascular risk factors
- Sample size
- about 5500
- Primary or secondary
- primary
- Peer review
- peer reviewed
- Retraction status
- None known
- Date checked
- 14 November 2026
Limitations
Sponsor-funded (Boehringer Ingelheim). Designed to test non-inferiority for cardiovascular events, not to show a cardiovascular benefit. Abstract read via Europe PMC; full text not read.
Cited in
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.